Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

Tech mogul and co-head of Department of Government Efficiency (DOGE), Elon Musk, defended the newly formed body’s efficiency ...

Barclays analyst downgrades Bath & Body Works citing supply & demand risks, increased inventory, & need for premium products. Stock price falls.

The key innovation here is a stable form of psilocin that, when taken, is gradually broken down into active psilocin in the ...

Donald Trump appoints Elon Musk and Vivek Ramaswamy to head the new Department of Government Efficiency (DOGE) to cut ...

BRTX-100 is a novel cell-based therapeutic engineered to target body areas with little blood flow. A Phase 2 study is ...

New Jersey sets a precedent by adding medical cannabis to government health plans, offering employee benefits for the first ...

SKYX Platforms ranks at the bottom for Revenue Growth and Gross Profit, indicating lower performance in these areas compared ...

Toyota plans to produce 2.5M vehicles/year in China by 2030, while shifting development and production operations for greater ...

Breton Technology has filed for a Hong Kong IPO, reporting strong growth for its business making and selling electric-powered ...

California DFPI revokes BlockFi's license for multiple violations, including failure to evaluate borrowers' ability to repay ...

Get Benzinga’s exclusive analysis and the top ... up to one year with a maturity date of two years from the first draw. Body and Mind has also amended its existing convertible debentures with ...